Trials / Unknown
UnknownNCT05386641
Risk Factors for Shoulder Joint Motion Restriction
Risk Factors for Shoulder Joint Motion Restriction in Breast Cancer Survivors
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 72 (estimated)
- Sponsor
- Istanbul Medeniyet University · Academic / Other
- Sex
- Female
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
In breast cancer patients, limitation of shoulder joint movement may occur following cancer treatment. Shoulder limitation causes a significant decrease in the patient's participation in activities of daily living. The aim of the study is to define these limitations, to evaluate in detail all the structures that cause the problem, and to determine the causes of the limitations in patients with shoulder joint movement limitation developed after breast cancer survivors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | measurement of tissue stiffness (N/m) | Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain |
| OTHER | measurement of passive muscle tone (Hz) | muscle tones will be measured with myotonPro on centers of coordination located along along the myofascial chain |
| OTHER | measurement of creep of tissue | creep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain |
| OTHER | measurement of the range of shoulder joint motion | The range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer. |
| OTHER | measurement of skin temperature | measurements will be taken by the thermographic camera |
| OTHER | measurement of pain | Pain will be evaluated by visual analog scale (VAS) |
| OTHER | measurement of pain pressure threshold | Pain pressure threshold will be evaluated by a digital algometer |
| OTHER | measurement of grip strength | The grip strength of both hand will be evaluated by "hand-held" dynamometer. |
Timeline
- Start date
- 2022-08-15
- Primary completion
- 2023-08-15
- Completion
- 2024-02-15
- First posted
- 2022-05-23
- Last updated
- 2022-05-31
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05386641. Inclusion in this directory is not an endorsement.